Virtu Financial’s AnaptysBio ANAB Stock Holding History

Virtu Financial’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.85M	Buy	+33,323	New	+$1.79M	0.08%	169
2025 Q4	–	Sell	-15,531	Closed	-$476K	–	1624
2025 Q3	$476K	Buy	+15,531	New	+$356K	0.03%	581
2024 Q2	–	Sell	-9,850	Closed	-$222K	–	1271
2024 Q1	$222K	Buy	+9,850	New	+$233K	0.02%	742
2018 Q1	–	Sell	-2,923	Closed	-$294K	–	1913
2017 Q4	$294K	Sell	2,923 -5,584	-66%	-$411K	0.02%	1288
2017 Q3	$297K	Buy	+8,507	New	+$229K	0.01%	1392

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Virtu Financial's ANAB Position: Q1 2026 in Review

Virtu Financial opened a new position in AnaptysBio (ANAB) in Q1 2026: 33,323 shares worth $1.85M. The stake represents 0.08% of the portfolio and ranks #169 among its holdings. This is a return to the name: Virtu Financial previously reported a position in ANAB as recently as Q3 2025.

Virtu Financial first reported a position in ANAB in Q3 2017 and has held it in 5 quarters since. 207 funds tracked by Wall St. Rank hold ANAB as of Q1 2026.

Virtu Financial held 33,323 shares of AnaptysBio worth $1.85M as of Q1 2026.
AnaptysBio was a new Virtu Financial position in Q1 2026.
AnaptysBio made up 0.08% of Virtu Financial's portfolio in Q1 2026, its #169 holding.
Virtu Financial first reported a position in AnaptysBio in Q3 2017 and has held it in 5 quarters since.
207 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.